• Doxycycline Workflows for MMP2 Cancer Research

  2026-09-02

  Use Doxycycline as a controlled metalloproteinase-inhibition tool, antiproliferative comparator, and antimicrobial agent for research. This workflow guide shows how to separate matrix effects from cytotoxicity and how to translate MMP2-responsive delivery concepts into reproducible assays.

• Anti-HMGB1 Rabbit Monoclonal Antibody Guide

  2026-09-02

  Anti-HMGB1 Rabbit Monoclonal Antibody MA3057 is a research reagent for detecting HMGB1 in human, mouse, and rat samples by Western blot, immunohistochemistry, and flow cytometry. It should be used for controlled assay development and chromatin protein detection only, not for diagnostic, therapeutic, or medical applications.

• Estradiol Benzoate: ERα Research Workflows

  2026-09-01

  Estradiol Benzoate provides a practical, high-affinity starting point for receptor binding, pathway activation, and species-aware estrogen studies. This guide combines solvent and assay optimization with a structure-based screening framework to improve reproducibility without overinterpreting computational or cellular readouts.

• Praeruptorin A Applied Research Workflows

  2026-09-01

  Build practical Praeruptorin A workflows for ferroptosis, inflammation, intestinal-barrier, cardiomyopathy, and hepatocellular-carcinoma studies. The article emphasizes dose selection, orthogonal readouts, pathway validation, and troubleshooting rather than relying on a single biomarker.

• EDC.HCl Coupling Workflow Guide

  2026-08-31

  EDC.HCl is a water-soluble carbodiimide used to activate carboxyl groups for amide bond formation with primary amines in peptide synthesis and bioconjugation workflows. It is intended for controlled in vitro laboratory use; the dossier reports no in vivo or clinical data, and long-term storage of solutions is not recommended.

• MG-132 Workflows for Proteasome Stress Assays

  2026-08-31

  MG-132 (Z-LLL-al) connects proteasome inhibition with practical apoptosis, cell-cycle, oxidative-stress, and protein-turnover readouts. This guide emphasizes dose mapping, imaging-compatible workflows, and troubleshooting that separates proteasome-specific biology from secondary toxicity.

• (R,S)-Anatabine Workflows for Alzheimer’s Research

  2026-08-30

  (R,S)-Anatabine provides a practical way to connect amyloid precursor protein processing with neuroinflammatory signaling in translational Alzheimer’s studies. This guide covers cell-based screening, soluble Aβ peptide reduction workflows, assay controls, and troubleshooting for more reproducible Anatabine experiments.

• RG108 Pharmacokinetics in Rats: Study Insights

  2026-08-29

  The reference study established an in vivo pharmacokinetic profile for RG108, a non-nucleosidic DNA methyltransferase inhibitor, after subcutaneous administration in rats. Its findings show measurable plasma and tissue exposure near reported inhibitory concentrations, supporting RG108 as a research tool for DNMT inhibition while leaving pharmacodynamic efficacy and long-term safety to be tested.

• Y5: A Dimer-Interface AR Antagonist

  2026-08-28

  This 2025 Journal of Medicinal Chemistry study identifies benzo[b]oxepine derivatives that inhibit androgen receptor signaling through a non-canonical dimer interface pocket rather than the mutation-prone ligand-binding pocket. Optimization produced Y5, which combines potent antagonism, activity against resistant AR variants, AR degradation, and oral efficacy in an LNCaP xenograft model.

• ECL Western Blotting Substrate: Workflow Guide

  2026-08-28

  ECL Western Blotting Substrate (SKU K2187) is a luminol-based horseradish peroxidase detection reagent for sensitive, nonradioactive protein detection by chemiluminescence on immunoblots. It is intended for HRP-linked Western blot assays using X-ray film or CCD imaging, not for fluorescent or radioisotopic detection workflows.

• Praeruptorin A: Assay Workflows and Applications

  2026-08-27

  Praeruptorin A converts an iron-centered screening concept into practical workflows for ferroptosis, doxorubicin cardiotoxicity, inflammation, and invasion studies. This guide emphasizes dose planning, orthogonal readouts, formulation control, and model-specific troubleshooting rather than relying on viability data alone.

• HCMV UL38, IRS1, and AKT Signal Dampening

  2026-08-27

  The reference study identifies HCMV UL38 as a viral driver of mTORC1-dependent IRS1 destabilization, explaining how infected cells become less responsive to serum-mediated AKT activation. Its combination of fractionation, live-cell imaging, viral genetics, ectopic expression, and rapamycin rescue provides a useful framework for distinguishing impaired AKT membrane recruitment from simple changes in total kinase abundance.

• Optimized hiPSC Platelet Differentiation: Study Insights

  2026-08-26

  A 2026 study in Stem Cell Reviews and Reports introduces an optimized differentiation scheme for generating functional platelets from human induced pluripotent stem cells. By increasing embryoid body input, refining serum-free medium with human platelet lysate, replacing selected cytokines with small molecules, and improving megakaryocyte maturation, the workflow shortened production, increased yield, and reduced estimated cost.

• Doxycycline: From MMP Biology to Translation

  2026-08-26

  Doxycycline is more than a tetracycline antibiotic: its metalloproteinase inhibition, antimicrobial activity, and antiproliferative potential make it a versatile research tool. This article translates recent abdominal aortic aneurysm nanomedicine findings into practical guidance for mechanism-driven vascular and cancer research.

• Batimastat (BB-94): Designing Causal MMP Assays

  2026-08-25

  Batimastat (BB-94) is a broad-spectrum hydroxamate MMP inhibitor with value beyond simple enzyme blockade. This guide shows how to use it to distinguish extracellular proteolysis, localized BDNF processing, tumor invasion, and assay-specific confounders.

8004 records 1/534 page Next 12345 下5页 Last page